Literature DB >> 31085440

Association and risk of five miRNAs with arsenic-induced multiorgan damage.

Qibing Zeng1, Zhonglan Zou1, Qingling Wang1, Baofei Sun1, Yonglian Liu1, Bing Liang1, Qizhan Liu2, Aihua Zhang3.   

Abstract

Chronic exposure to arsenic remains a major environmental public health concern worldwide, affecting hundreds of millions of people. Arsenic-induced multiorgan damage and miRNA expression changes after arsenic exposure have been determined, but their associations and risks have not been fully examined. In this study, we measured the expression levels of five miRNAs in plasma from control and arsenic poisoned populations, and we analyzed the relationship between miRNAs and multiorgan damage. The results clearly show that the upregulation of miR-155 expression can increase the risk of arsenic induced skin damage (OR = 10.55; 95% CI: 6.02, 18.47); further, there is a link between the expression of miR-21 (OR = 11.84; 95% CI: 5.34, 26.28) and miR-145 (OR = 2.39; 95% CI: 1.61, 3.55) and liver damage, and miR-191 and kidney damage (OR = 3.65; 95% CI: 1.49, 8.93). In addition, we analyzed the diagnostic value of miRNAs associated with specific organ damage in arsenic-induced multiorgan damage. It was found that the miR-155 has a certain diagnostic value in arsenic-induced skin damage (AUC = 0.83), miR-21 and miR-145 have diagnostic value for liver damage (AUC = 0.80, 0.81) and miR-191 has diagnostic value for kidney damage (AUC = 0.83). This study provides the first comprehensive assessment of the association and risk of five miRNAs with arsenic-induced multiorgan damage. The study can provide a scientific basis for further understanding the causes of arsenic-induced multiorgan damage, identification of possible biological markers, and improvement of targeted prevention and control strategies.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arsenic; Kidney damage; Liver damage; Risk; Skin damage; miRNAs

Mesh:

Substances:

Year:  2019        PMID: 31085440     DOI: 10.1016/j.scitotenv.2019.05.042

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  6 in total

1.  Circulating let-7g-5p and miR-191-5p Are Independent Predictors of Chronic Kidney Disease in Hypertensive Patients.

Authors:  Olga Berillo; Ku-Geng Huo; Júlio C Fraulob-Aquino; Chantal Richer; Marie Briet; Pierre Boutouyrie; Mark L Lipman; Daniel Sinnett; Pierre Paradis; Ernesto L Schiffrin
Journal:  Am J Hypertens       Date:  2020-05-21       Impact factor: 2.689

2.  Assessing the Role of Nrf2/GPX4-Mediated Oxidative Stress in Arsenic-Induced Liver Damage and the Potential Application Value of Rosa roxburghii Tratt [Rosaceae].

Authors:  Yuyan Xu; Qibing Zeng; Baofei Sun; Shaofeng Wei; Qingling Wang; Aihua Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-04-25       Impact factor: 7.310

3.  Assessing the Association of Element Imbalances With Arsenism and the Potential Application Value of Rosa roxburghii Tratt Juice.

Authors:  Yuyan Xu; Baofei Sun; Qibing Zeng; Shaofeng Wei; Guanghong Yang; Aihua Zhang
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

Review 4.  Arsenic-induced changes in miRNA expression in cancer and other diseases.

Authors:  Ana P Ferragut Cardoso; Karen T Udoh; J Christopher States
Journal:  Toxicol Appl Pharmacol       Date:  2020-10-28       Impact factor: 4.219

5.  Ginkgo biloba extract attenuates the disruption of pro-and anti-inflammatory T-cell balance in peripheral blood of arsenicosis patients.

Authors:  Shiqing Xia; Qian Sun; Zhonglan Zou; Yonglian Liu; Xiaolin Fang; Baofei Sun; Shaofeng Wei; Dapeng Wang; Aihua Zhang; Qizhan Liu
Journal:  Int J Biol Sci       Date:  2020-01-01       Impact factor: 6.580

6.  The Molecular Mechanism of Hepatic Lipid Metabolism Disorder Caused by NaAsO2 through Regulating the ERK/PPAR Signaling Pathway.

Authors:  Liping Wu; Shuling Zhang; Qi Zhang; Shaofeng Wei; Guoze Wang; Peng Luo
Journal:  Oxid Med Cell Longev       Date:  2022-03-14       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.